Prebiotics were first defined as "nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacterial species already resident in the colon, and thus attempt to improve host health".^[@ref1]^ This concept has been updated and adapted many times,^[@ref2]−[@ref4]^ but there is no doubt that galactooligosaccharides (GOS) make up an important category of prebiotics. GOS are a mixture of oligosaccharides produced from lactose by β-galactosidase enzymes, comprising a number of galactose units, with a terminal glucose or galactose.^[@ref5]−[@ref7]^ They are produced via the double-displacement reaction catalyzed by β-galactosidase enzymes. In the first step, the glycosidic linkage of lactose is cleaved, and the galactosyl unit covalently binds to the enzyme forming a galactosyl--enzyme intermediate while releasing the glucose. In the second step, an acceptor substrate attacks the intermediate, resulting in formation of a product with the galactosyl moiety. β-Galactosidase enzymes perform two reactions depending on the acceptor substrate. With water serving as the acceptor substrate, galactose is released via hydrolysis; with lactose or other carbohydrates serving as acceptor substrates, GOS products are formed via transgalactosylation.^[@ref8]−[@ref11]^

β-Galactosidase enzymes belong to glycoside hydrolase (GH) families 1, 2, 35, and 42.^[@ref12]^ The β-galactosidase from *Bacillus circulans* ATCC 31382 (BgaD, GH2) is a 189 kDa enzyme, and its commercial preparation, Biolacta N5, is widely used in the food industry.^[@ref13]−[@ref15]^ BgaD has an activity toward lactose higher than those of and a thermal stability better than those of other β-galactosidase enzymes.^[@ref16]^ A study investigated the influence of organic solvents on the regioselectivity of BgaD transglycosylation.^[@ref17]^ The product specificity of BgaD with lactose as a substrate was studied using methylation analysis, mass spectrometry (MS), and nuclear magnetic resonance spectroscopy; in this way, 11 GOS structures were identified.^[@ref18]^ A detailed analysis of the commercial product Vivinal GOS, synthesized by the *B. circulans* enzyme, resulted in identification of a total of 43 GOS structures.^[@ref6],[@ref7]^ In *B. circulans*, BgaD is present in different isoforms resulting from C-terminal cleavage by an endogenous protease.^[@ref19]^ Three isoforms were reported by Vetere and Paoletti;^[@ref20]^ four isoforms (BgaD-A, BgaD-B, BgaD-C, and BgaD-D) were reported in the commercial enzyme preparation of β-galactosidase from *B. circulans*.^[@ref19]^ In recent years, these BgaD isoforms have been characterized in more detail, facilitated by their cloning and recombinant overexpression in *Escherichia coli*.^[@ref21]^ All four isoforms have similar transgalactosylation activity at high lactose concentrations.^[@ref9],[@ref22]^ The products synthesized by recombinant BgaD-D were also studied in detail, showing a product profile similar to that of Vivinal GOS.^[@ref6],[@ref7],[@ref10]^ Mutagenesis studies have shown that the C-terminal discoidin domain of BgaD is essential for the hydrolytic activity of the enzyme.^[@ref23]^ A few BgaD-D mutants have been biochemically characterized in our previous work, resulting in identification of residues Glu532 and Glu447 as the nucleophile and acid/base catalysts, respectively.^[@ref9]^ Mutagenesis of the Arg484 changed the GOS linkage specificity.^[@ref11]^

The high-resolution crystal structure of the shortest isoform of β-galactosidase from *B. circulans* \[BgaD-D, Protein Data Bank (PDB) code 4YPJ\] was reported recently.^[@ref24]^ Details of the structure--function relationships of this enzyme determining its GOS product linkage specificity have remained unknown. Here we report the identification and site-directed mutagenesis of further residues in the active site of BgaD-D. Their functional roles were characterized by analyzing the biochemical properties of the mutant enzymes and the structures of the GOS produced. The data provide insight into how these residues contribute to determining enzyme activity and GOS linkage specificity.

Experimental Procedures {#sec2}
=======================

Bacterial Strains {#sec2.1}
-----------------

*E. coli* DH5α (Phabagen) was used for DNA manipulation, and *E. coli* BL21 (DE3) was used for protein expression.

Sequence and Structure Alignment {#sec2.2}
--------------------------------

T-Coffee and Jalview were used for the alignment of the amino acid sequences of β-galactosidases from GH2 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}): BgaD-D (E5RWQ2) from *B. circulans* ATCC 31382, BgaA (A0A0H2UP19) from *Streptococcus pneumoniae* serotype 4, BIF3 (Q9F4D5) from *Bifidobacterium bifidum* DSM 20215, BbgIII (A4K5H9) from *Bi. bifidum* NCIMB 41171, and BbgIII (D4QAP3) from *Bi. bifidum*. PyMOL (The PyMOL Molecular Graphics System, version 1.2, Schrödinger, LLC) was used for the structural alignment ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) of BgaD-D from *B. circulans* (PDB code 4YPJ) and the nucleophile mutant (E645Q) of BgaA in complex with *N*-acetyl-lactosamine (LacNAc) from *S. pneumoniae* (PDB code 4CUC).

###### Comparison of the Amino Acid Sequences of β-Galactosidase BgaD-D from *B. circulans* ATCC 31382 and Other β-Galactosidases in the GH2 Family

  enzyme name   enzyme source                identity (%)   UniProt code   PDB code
  ------------- ---------------------------- -------------- -------------- ----------
  BgaD-D        *B. circulans* ATCC 31382    100            E5RWQ2         4YPJ
  BgaA          *S. pneumoniae* serotype 4   49             A0A0H2UP19     4CU6
  BIF3          *Bi. bifidum* DSM 20215      44             Q9F4D5          
  BbgIII        *Bi. bifidum* NCIMB 41171    43             A4K5H9          
  BbgIII        *Bi. bifidum*                26             D4QAP3         5DMY

![Sequence alignment of β-galactosidase enzymes in the GH2 family. Residues selected for mutagenesis and the catalytic residues in BgaD-D from *B. circulans* ATCC 31382, Arg185, Glu447 (acid/base catalyst), Asp481, Lys487, Tyr511, Glu532 (nucleophile), Trp570, Trp593, Glu601, and Phe616, are denoted with red arrows. The order of the sequences shown is the same as those listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The amino acid residue color coding used is in Clustal X format. For details, see <http://www.jalview.org/help/html/colourSchemes/clustal.html>; gaps in the alignments are denoted with hyphens.](bi-2017-00207h_0001){#fig1}

![Stereoview of the superposition of the active sites of the β-galactosidases BgaD-D (PDB code 4YPJ) of *B. circulans* ATCC 31382 and the nucleophile mutant E645Q of BgaA from *S. pneumoniae* in complex with LacNAc (PDB code 4CUC). 4YPJ is colored slate blue and 4CUC brown, and the catalytic residues of BgaD-D are colored cyan. Residues of BgaD-D are labeled in black and the corresponding residues in BgaA in gray.](bi-2017-00207h_0002){#fig2}

Site-Directed Mutagenesis {#sec2.3}
-------------------------

Plasmid pET-15b-LIC containing the rBgaD-D-encoding gene from *B. circulans* was obtained from a previous study and used as a template for site-directed mutagenesis.^[@ref10]^ On the basis of the results of the sequence and structure alignments, mutations of residues Arg185, Asp481, Lys487, Tyr511, Trp570, Trp593, Glu601, and Phe616 were introduced by various primers ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00207/suppl_file/bi7b00207_si_001.pdf)) using the QuikChange site-directed mutagenesis kit (Stratagene). The polymerase chain reaction (PCR) products were cleaned up with a PCR purification kit after digestion by DpnI (Thermo Fisher). Then the PCR products were transformed into *E. coli* DH5α competent cells (Phabagen) via heat shock for overnight growth on LB agar plates (containing 100 μg/mL ampicillin). For every mutant, colonies were randomly chosen and inoculated into 5 mL of LB medium (containing 100 μg/mL ampicillin) for DNA amplification overnight. The plasmid DNA of the overnight cultures was purified using a miniprep kit (Sigma-Aldrich) and sequenced (GATC Biotech).

Recombinant Protein Expression and Purification {#sec2.4}
-----------------------------------------------

The sequence-verified plasmids were transformed into *E. coli* BL21 (DE3) (Invitrogen) competent cells for protein expression as described previously.^[@ref10]^ Briefly, after growth on LB agar plates (containing 100 μg/mL ampicillin), colonies were inoculated into 10 mL of LB medium (containing 100 μg/mL ampicillin) for overnight preculture. The overnight cultures were inoculated into 1 L of LB medium (containing 100 μg/mL ampicillin) and incubated at 37 °C until the cell density reached 0.6 at 600 nm; then 1 mM isopropyl β-[d]{.smallcaps}-thiogalactopyranoside was used for the induction of recombinant protein expression. The cells were cultured at 30 °C overnight and harvested by centrifugation at 10876*g* for 15 min. The cell pellets were washed with 20 mM Tris-HCl buffer (pH 8.0) and centrifuged again.

The cell pellets were lysed with B-PER protein extract reagent (Thermo Scientific) at room temperature for 1 h. The cell debris was removed by centrifugation; the remaining supernatants were mixed with HIS-Select Nickel Affinity Gel (Sigma) and incubated at 4 °C overnight. Unbound proteins were washed away with 20 mM Tris-HCl (pH 8.0) and 50 mM NaCl. The recombinant proteins were eluted with 20 mM Tris-HCl (pH 8.0) and 50 mM NaCl containing 100 mM imidazole. Subsequently, the imidazole was removed by ultrafiltration (30 kDa cutoff, Amicon, Merck)

Enzyme Activity Assay {#sec2.5}
---------------------

For the activity assay of the wild-type and mutant enzymes, 0.5--1 mg/mL (protein concentration determined by a Nanodrop 2000 UV--vis spectrophotometer) amounts were incubated with 10% (w/w) lactose in 100 mM sodium phosphate buffer (pH 6.0) for 5 min at 40 °C. The incubation mixtures were withdrawn and immediately inactivated with 50 μL of 1.5 M NaOH. The reaction mixtures were neutralized with 50 μL of 1.5 M HCl after 10 min. The total activity (units) toward lactose was defined as the amount of enzyme required to release 1 μmol of Glc/min. The released glucose was measured using a GOPOD kit ([d]{.smallcaps}-glucose Assay Kit, Megazyme). The activity of the wild-type enzyme was regarded as 100%; activities of all mutant enzymes were relative to that of the wild-type enzyme. The kinetic parameters (*K*~m~ and *k*~cat~) of mutant enzymes were determined using 10 different lactose concentrations ranging from 10 to 500 mM.

GOS Production and Analysis {#sec2.6}
---------------------------

GOS were produced by using 3.75 units/g lactose β-galactosidase wild-type and mutant enzymes with 50% (w/w) lactose \[in 100 mM sodium phosphate buffer (pH 6.0)\] incubated at 60 °C for 20 h to reach the highest GOS yield. We stopped the reactions by heating the mixtures at 100 °C for 10 min.

The reaction mixtures were diluted 1000-fold with Milli-Q water and analyzed by high-pH anion exchange chromatography (HPAEC) coupled with a pulsed amperometric detector (PAD) on an ICS3000 chromatography workstation (ThermoScientific). The analysis was performed by injecting 5 μL on a CarboPac PA1 analytical column (2 mm × 250 mm) with the following elution buffers: (A) 100 mM sodium hydroxide, (B) 600 mM sodium acetate in 100 mM sodium hydroxide, (C) Milli-Q water, and (D) 50 mM sodium acetate. The separation conditions were the same as used in our previous study.^[@ref10]^ The quantity of β-[d]{.smallcaps}-Gal*p*-(1→3)-β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p* was determined by using a calibration curve of this compound (Sigma) ranging from 4 to 200 μg/mL. The comparisons of other GOS fractions were based on the peak intensities of HPAEC--PAD profiles of the wild-type and mutant enzymes. The quantification of the GOS yield {GOS yield (grams) = initial lactose (grams) -- \[remaining lactose (grams) + galactose (grams) + glucose (grams)\] after 20 h} was based on a calibration curve of galactose, glucose, and lactose ranging from 10 to 1000 μM.

Results {#sec3}
=======

Structural Alignment {#sec3.1}
--------------------

The β-galactosidase proteins BgaD-D of *B. circulans* and BgaA of *S. pneumonia* share 49% sequence identity. A structural alignment of BgaD-D (PDB code 4YPJ) with the catalytic region of BgaA (PDB code 4CU6) and with the inactive BgaA mutant E645Q in complex with LacNAc (PDB code 4CUC) ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) guided our selection of active site residues to be mutated. The residues targeted for mutagenesis were grouped in four sets, mainly based on their location in the active site.

Site-Directed Mutagenesis and Enzyme Activity {#sec3.2}
---------------------------------------------

Mutations were introduced by site-directed random mutagenesis as described in [Experimental Procedures](#sec2){ref-type="other"}. The mutants were obtained via two rounds of mutagenesis. Universal primer pairs ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00207/suppl_file/bi7b00207_si_001.pdf)) were used for the first round, and 20 colonies were selected randomly for sequencing. Specific primers ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00207/suppl_file/bi7b00207_si_001.pdf)) were used in the second round of mutagenesis for a full coverage of amino acid (side chain) classes, or to obtain a specific amino acid residue. The mutants obtained in the two mutagenesis rounds and their relative enzyme activities (release of Glc from lactose) are listed in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. For residues Arg185, Glu601, and Tyr511, a total of 6, 11, and 5 different mutants were obtained after two rounds, respectively; all mutants were completely inactive ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Four Trp570 mutants were found in the first round of mutagenesis; another six mutants were selected in the second round. Of these mutants, Trp570Tyr had the highest activity, 37.4 ± 0.4% compared to that of the wild-type enzyme, followed by Trp570Phe (16.1 ± 1.0%) and Trp570Leu (14.6 ± 0.8%). The activity of the other Trp570 mutants was rather low ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). One round of Trp593 mutagenesis yielded a total of 11 mutants. Among them, only Trp593Tyr and Trp593Phe retained activity, 3.3 ± 0.2 and 70.7 ± 0.7% of the wild-type enzyme activity, respectively ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). For Phe616, a total of eight mutants were obtained in the first round. With the specific primers, the other 11 mutants were also obtained. Phe616Trp (37.2 ± 1.5%) and Phe616Tyr (73.2 ± 0.6%) had the highest activity among all these mutants ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). In the first round, six mutants of Asp481 were acquired, and another seven mutants were obtained in the second round. Only Asp481Glu, Asp481His, Asp481Ser, Asp481Asn, and Asp481Gln retained very little activity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). For Lys487, the universal primers resulted in eight mutants; most of them had relatively high activity (65.5 ± 0.8 to 105.5 ± 1.2%), except for Lys487Cys (3.5 ± 0.4%) ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

###### Relative Total Activities (release of Glc from lactose) of the Various *B. circulans* ATCC 31382 β-Galactosidase BgaD-D Mutant Proteins

  site     round   mutant   relative activity[a](#t2fn1){ref-type="table-fn"}   site     round   mutant   relative activity
  -------- ------- -------- --------------------------------------------------- -------- ------- -------- ----------------------------------
                   WT       100                                                 Phe616   1       Val      1.9 ± 0.01
  Arg185   1       Glu      [b](#t2fn2){ref-type="table-fn"}                                     Glu      1.4 ± 0.01
                   Gly      [b](#t2fn2){ref-type="table-fn"}                                     Gly      3 ± 0.1
                   Leu      [b](#t2fn2){ref-type="table-fn"}                                     Lys      0.8 ± 0.01
                   Pro      [b](#t2fn2){ref-type="table-fn"}                                     Gln      3.2 ± 0.08
                   Ser      [b](#t2fn2){ref-type="table-fn"}                                     Arg      1.3 ± 0.01
                   Lys      [b](#t2fn2){ref-type="table-fn"}                                     Asp      4.6 ± 0.1
  Glu601   1       Pro      [b](#t2fn2){ref-type="table-fn"}                                     Leu      22.9 ± 1.6
                   Phe      [b](#t2fn2){ref-type="table-fn"}                             2       Trp      37.2 ± 1.5
                   Gln      [b](#t2fn2){ref-type="table-fn"}                                     His      13.4 ± 0.2
                   His      [b](#t2fn2){ref-type="table-fn"}                                     Ser      5.3 ± 1.1
                   Ala      [b](#t2fn2){ref-type="table-fn"}                                     Thr      4.9 ± 0.03
                   Arg      [b](#t2fn2){ref-type="table-fn"}                                     Asn      11.6 ± 0.1
                   Tyr      [b](#t2fn2){ref-type="table-fn"}                                     Cys      3.9 ± 0.08
                   Cys      [b](#t2fn2){ref-type="table-fn"}                                     Pro      3.8 ± 0.7
                   Gly      [b](#t2fn2){ref-type="table-fn"}                                     Ala      3.4 ± 0.1
                   Thr      [b](#t2fn2){ref-type="table-fn"}                                     Ile      2.8 ± 0.04
           2       Asp      [b](#t2fn2){ref-type="table-fn"}                                     Met      1.4 ± 0.05
  Tyr511   1       Cys      [b](#t2fn2){ref-type="table-fn"}                                     Tyr      73.2 ± 0.6
                   Pro      [b](#t2fn2){ref-type="table-fn"}                    Asp481   1       Tyr      [b](#t2fn2){ref-type="table-fn"}
                   Ser      [b](#t2fn2){ref-type="table-fn"}                                     Phe      [b](#t2fn2){ref-type="table-fn"}
           2       Trp      [b](#t2fn2){ref-type="table-fn"}                                     Glu      7.3 ± 0.5
                   Phe      [b](#t2fn2){ref-type="table-fn"}                                     His      2.1 ± 0.6
  Trp570   1       Gly      5.1 ± 0.08                                                           Ala      [b](#t2fn2){ref-type="table-fn"}
                   Thr      6.5 ± 0.2                                                            Ser      6.1 ± 0.2
                   Arg      3.6 ± 0.1                                                    2       Lys      [b](#t2fn2){ref-type="table-fn"}
                   Glu      5.2 ± 0.3                                                            Arg      [b](#t2fn2){ref-type="table-fn"}
           2       Tyr      37.4 ± 0.4                                                           Asn      6.7 ± 0.3
                   Phe      16.1 ± 1.0                                                           Gln      3.3 ± 0.3
                   Ala      4.2 ± 0.05                                                           Leu      [b](#t2fn2){ref-type="table-fn"}
                   Val      3.0 ± 0.1                                                            Trp      [b](#t2fn2){ref-type="table-fn"}
                   Cys      6.1 ± 0.1                                                            Gly      [b](#t2fn2){ref-type="table-fn"}
                   Leu      14.6 ± 0.8                                          Lys487   1       Met      105.5 ± 1.2
  Trp593   1       Val      [b](#t2fn2){ref-type="table-fn"}                                     Phe      73.2 ± 0.7
                   Leu      [b](#t2fn2){ref-type="table-fn"}                                     Leu      93.7 ± 0.4
                   Ser      [b](#t2fn2){ref-type="table-fn"}                                     Gln      83.1 ± 0.6
                   Ala      [b](#t2fn2){ref-type="table-fn"}                                     Ser      76.3 ± 0.9
                   Gly      [b](#t2fn2){ref-type="table-fn"}                                     Gly      65.5 ± 0.9
                   Thr      [b](#t2fn2){ref-type="table-fn"}                                     Asn      65.5 ± 0.8
                   Pro      [b](#t2fn2){ref-type="table-fn"}                                     Cys      3.5 ± 0.4
                   Gln      [b](#t2fn2){ref-type="table-fn"}                                               
                   Tyr      3.3 ± 0.2                                                                      
                   Phe      70.7 ± 0.7                                                                     
                   His      [b](#t2fn2){ref-type="table-fn"}                                               

Total activity. Activities of all mutant enzymes are relative to that of the wild-type (WT) enzyme (100%, 103.4 μmol min^--1^ mg^--1^). Enzyme activity was measured in triplicate experiments with 10% (w/w) lactose at 40 °C.

Activity not detectable (detection limit of 0.1 mg/mL glucose).

Catalytic Properties {#sec3.3}
--------------------

On the basis of the activity compared to that of the wild-type (WT) enzyme, and interesting product profiles (see the next section), the catalytic properties of a selection of enzymes were determined ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). For all enzymes, the *k*~cat~ was lower (12.3 ± 1.1 to 184.7 ± 3.4 s^--1^) than that of the WT enzyme (199.8 ± 5.3 s^--1^), while the substrate affinity (*K*~m~) ranged from 21.9 ± 4.7 to 246.5 ± 66.0 mM; the WT enzyme has a *K*~m~ of 112.9 ± 12.7 mM.^[@ref11]^ The catalytic efficiency (*k*~cat~/*K*~m~) of the WT enzyme is 1780.7 ± 152.0 s^--1^ M^--1^; in almost all mutants, the efficiency was lower (178.4 ± 16.5 to 1546.3 ± 50.0 s^--1^ M^--1^), except for Trp593Phe that has a much higher *k*~cat~/*K*~m~ of 2990.2 ± 184.2 s^--1^ M^--1^.

###### Kinetic Properties of the *B. circulans* ATCC 31382 Wild-Type β-Galactosidase BgaD-D and Mutant Proteins

  enzyme                               *K*~m~[a](#t3fn1){ref-type="table-fn"} (mM)   *k*~cat~[a](#t3fn1){ref-type="table-fn"} (s^--1^)   *k*~cat~/*K*~m~ (s^--1^ M^--1^)
  ------------------------------------ --------------------------------------------- --------------------------------------------------- ---------------------------------
  WT[b](#t3fn2){ref-type="table-fn"}   112.9 ± 12.7                                  199.8 ± 5.3                                         1780.7 ± 152.0
  Trp570Tyr                            75.6 ± 11.0                                   27.2 ± 0.9                                          398.6 ± 20.0
  Trp570Phe                            246.5 ± 66.0                                  44.6 ± 7.1                                          178.4 ± 16.5
  Trp593Phe                            21.9 ± 4.7                                    63.6 ± 0.6                                          2990.2 ± 184.2
  Phe616Trp                            180.0 ± 8.0                                   114.7 ± 3.5                                         587.7 ± 5.2
  Phe616His                            156.1 ± 9.8                                   48.9 ± 1.8                                          321.3 ± 27.2
  Phe616Tyr                            112.6 ± 3.9                                   183.9 ± 4.0                                         1504.6 ± 57.2
  Asp481Gln                            57.4 ± 13.8                                   12.3 ± 1.1                                          217.9 ± 37.9
  Lys487Ser                            119.5 ± 5.6                                   184.7 ± 3.4                                         1546.3 ± 50.0
  Lys487Gly                            176.8 ± 12.6                                  177.7 ± 7.1                                         1001.5 ± 37.2

Kinetic parameters (*K*~m~ and *k*~cat~) were determined with 10 different lactose concentrations ranging from 10 to 500 mM.

Data from our previous study.^[@ref11]^

Mutant GOS Profiles {#sec3.4}
-------------------

For the wild type (WT) and a selection of mutant enzymes showing sufficient activity, incubations using 3.75 units/g of lactose were performed for 20 h, and the HPAEC--PAD GOS product profiles were compared ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).

![HPAEC--PAD analysis of the GOS profiles produced by *B. circulans* ATCC 31382 BgaD-D WT and mutant enzymes: (A) Trp570 mutants, (B) Trp593 mutants, (C) Phe616 mutants, (D) Asp481 mutants, (E) Lys487 mutants, and (F) the annotated major GOS structures. WT and mutant enzymes (3.75 units/g of lactose) were incubated with 50% (w/w) lactose (structure **5**) for 20 h at 60 °C.](bi-2017-00207h_0003){#fig3}

Because galactose is released by hydrolysis, the hydrolysis activity is reflected by the intensity of peak **1** (galactose). For all three Trp570 mutants, the hydrolysis activity increased, as evidenced by the increased intensity of peak **1** in the HPAEC--PAD profile ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), whereas the hydrolytic activity of all Trp593 and Phe616 mutant enzymes was comparable with that of the WT enzyme \[peak **1** ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B,C)\]. Most notable changes in relative product intensities were observed in structures **8**, **11**, **13**, and **17** for the mutant enzymes at Trp570, Trp593, and Phe616 ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). In the case of Trp570Tyr and Trp570Phe, structures **8a** \[β-[d]{.smallcaps}-Gal*p*-(1→2)-[d]{.smallcaps}-Glc*p*\] and **8b** \[β-[d]{.smallcaps}-Gal*p*-(1→3)-[d]{.smallcaps}-Glc*p*\] were similar in level to that of the WT enzyme, whereas the levels of the (β1→4) elongations (peaks **13a** and **13b**) significantly increased. Levels of structures **11** \[β-[d]{.smallcaps}-Gal*p*-(1→4)-β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p*\] and its (β1→4) elongation (peak **17**) were significantly decreased. In the case of Trp593Tyr and Trp593Phe, a similar observation was made, except that levels of structures **8a** and **8b** also were increased compared to the WT product profile. Mutant Trp570Leu showed a completely different profile, with a hydrolytic activity much higher than those of any of the other mutants. The HPAEC--PAD profile showed two major product peaks for **11** and **17** and only minor peaks for other products. However, quantitation of the peaks ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}) showed that peak **11** is comparable with that of the WT enzyme, while all other peaks showed a reduced product yield.

###### Total GOS Yields and Yields of the Major GOS Structures **8**, **11**, **13**, and **17** Obtained for the *B. circulans* ATCC 31382 BgaD-D Trp570, Trp593, and Phe616 Mutants, Compared to the Wild-Type Enzyme[a](#t4fn1){ref-type="table-fn"}

  enzyme                               GOS yield[b](#t4fn2){ref-type="table-fn"}   structure **8** yield[c](#t4fn3){ref-type="table-fn"}   structure **11** yield[c](#t4fn3){ref-type="table-fn"}   structure **13** yield[c](#t4fn3){ref-type="table-fn"}   structure **17** yield[c](#t4fn3){ref-type="table-fn"}
  ------------------------------------ ------------------------------------------- ------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------
  WT[d](#t4fn4){ref-type="table-fn"}   63.5 ± 0.8                                  100                                                     100                                                      100                                                      100
  Trp570Tyr                            65.8 ± 1.7                                  133.5 ± 0.9                                             52.7 ± 1.0                                               103.8 ± 1.6                                              41.3 ± 1.0
  Trp570Phe                            65.4 ± 0.9                                  110.1 ± 0.7                                             44.1 ± 0.5                                               91.6 ± 2.0                                               31.0 ± 0.6
  Trp570Leu                            43.8 ± 0.7                                  21.8 ± 0.5                                              93.9 ± 3.1                                               [e](#t4fn5){ref-type="table-fn"}                         67.9 ± 2.7
  Trp593Phe                            66.0 ± 1.0                                  122.5 ± 5.1                                             65.7 ± 1.7                                               126.2 ± 5.1                                              53.7 ± 1.6
  Trp593Tyr                            65.2 ± 2.1                                  146.6 ± 7.2                                             49.3 ± 2.1                                               128.4 ± 1.9                                              35.4 ± 1.9
  Phe616Trp                            50.8 ± 2.4                                  80.8 ± 1.7                                              132.1 ± 7.2                                              75.7 ± 0.8                                               119.8 ± 6.0
  Phe616Leu                            61.0 ± 1.4                                  114.4 ± 1.6                                             91.3 ± 3.1                                               120.2 ± 2.5                                              82.7 ± 3.3
  Phe616His                            59.6 ± 1.2                                  99.8 ± 3.3                                              93.4 ± 1.5                                               110.6 ± 0.8                                              80.4 ± 2.4
  Phe616Asn                            57.3 ± 1.4                                  82.0 ± 2.6                                              106.5 ± 8.0                                              93.6 ± 4.7                                               97.3 ± 9.6
  Phe616Tyr                            58.3 ± 0.6                                  105.9 ± 4.3                                             108.0 ± 0.1                                              114.9 ± 2.0                                              108.3 ± 0.5

GOS was produced using 3.75 units/mL β-galactosidase wild-type and mutant enzymes with 50% (w/w) lactose \[in 100 mM sodium phosphate buffer (pH 6.0)\] incubated at 60 °C for 20 h.

Yields are calculated as grams of GOS produced from 100 g of initial lactose. Calibration curves for lactose, galactose, and glucose ranging from 10 to 1000 μM were used for quantification.

The yields are relative to that of the wild-type enzyme (100%), estimated by comparing the peak intensities in the HPAEC--PAD profiles.

Data from our previous study.^[@ref11]^

Unable to quantify.

Enzymes with a mutation at Phe616 showed HPAEC--PAD profiles very similar to that of the WT enzyme. Quantitation of peaks **8**, **11**, **13**, and **17** showed some differences in intensity compared with the WT enzyme, but the changes were mostly minor. In case of Phe616 Trp, -Asn, and -Tyr mutants, levels of structures **11** and **17** were slightly increased, while levels of **8** and **13** were either slightly decreased or the same compared to that of the WT. For the other Phe616 mutants, the intensities showed the opposite response ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}).

Mutations at Asp481 and Lys487 showed different effects on the product profiles ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D,E). Mutation of Asp481 to Glu, Ser, or Asn reduced the intensity of peaks **8**, **11**, and **13** ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}), whereas the intensity of peak **12** \[β-[d]{.smallcaps}-Gal*p*-(1→3)-β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p*\] increased significantly. Whereas the WT enzyme produces only minor amounts of **12** (0.2 ± 0.05 g/100 g of lactose), all three mutants produced a significant amount of **12**. Notably, in case of Asp481Asn, the intensity of peak **4** \[β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p*\] also was increased ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D).

###### Total GOS Yields and Yields of the Major GOS Structures **8** and **11--13** Obtained for the *B. circulans* ATCC 31382 BgaD-D Asp481 and Lys487 Mutants, Compared to the Wild-Type Enzyme[a](#t5fn1){ref-type="table-fn"}

  enzyme                               GOS yield[b](#t5fn2){ref-type="table-fn"}   structure **8** yield[c](#t5fn3){ref-type="table-fn"}   structure **11** yield[c](#t5fn3){ref-type="table-fn"}   structure **12** yield[d](#t5fn4){ref-type="table-fn"}   structure **13** yield[c](#t5fn3){ref-type="table-fn"}
  ------------------------------------ ------------------------------------------- ------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------
  WT[e](#t5fn5){ref-type="table-fn"}   63.5 ± 0.8                                  100                                                     100                                                      0.2 ± 0.05                                               100
  Asp481Glu                            56.4 ± 2.2                                  51.5 ± 2.0                                              47.5 ± 1.5                                               4.8 ± 0.8                                                17.1 ± 3.2
  Asp481Ser                            55.3 ± 3.6                                  59.3 ± 1.9                                              70.1 ± 4.1                                               2.6 ± 0.4                                                30.3 ± 3.1
  Asp481Asn                            68.8 ± 1.7                                  68.5 ± 2.9                                              16.6 ± 0.8                                               4.9 ± 0.8                                                20.2 ± 4.7
  Lys487Met                            59.0 ± 1.9                                  99.8 ± 1.5                                              97.3 ± 3.2                                               [f](#t5fn6){ref-type="table-fn"}                         103.2 ± 3.4
  Lys487Phe                            58.3 ± 1.5                                  74.7 ± 0.2                                              105.6 ± 1.3                                              1.6 ± 0.2                                                68.7 ± 1.0
  Lys487Leu                            59.1 ± 1.1                                  101.3 ± 0.7                                             101.9 ± 2.4                                              [f](#t5fn6){ref-type="table-fn"}                         97.7 ± 4.1
  Lys487Gln                            58.6 ± 2.9                                  98.9 ± 1.2                                              98.8 ± 1.7                                               [f](#t5fn6){ref-type="table-fn"}                         98.1 ± 2.9
  Lys487Ser                            63.6 ± 1.0                                  77.5 ± 3.1                                              68.2 ± 1.3                                               5.0 ± 0.4                                                57.5 ± 3.7
  Lys487Gly                            62.0 ± 2.7                                  63.1 ± 0.2                                              66.0 ± 2.7                                               9.7 ± 1.1                                                36.9 ± 3.7
  Lys487Asn                            59.8 ± 1.3                                  68.5 ± 1.8                                              104.4 ± 5.0                                              1.7 ± 0.2                                                58.5 ± 2.0

GOS was produced using 3.75 units/mL β-galactosidase wild-type and mutant enzymes with 50% (w/w) lactose \[in 100 mM sodium phosphate buffer (pH 6.0)\] incubated at 60 °C for 20 h.

Yields are calculated as grams of GOS produced from 100 g of initial lactose. Calibration curves for lactose, galactose, and glucose ranging from 10 to 1000 μM were used for quantification.

The yields are relative to that of the wild-type enzyme (100%), estimated by comparing the peak intensities in the HPAEC--PAD profiles.

Yields are expressed as grams of product obtained from 100 g of initial lactose. A calibration curve of structure **12** \[β-[d]{.smallcaps}-Gal*p*-(1→3)-β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p*\] ranging from 4 to 200 μg/mL was used for its quantification.

Data from our previous study.^[@ref11]^

Not detectable.

Changing Lys487 to a Met, Leu, or Gln had no significant effect on the product profile, also evidenced by quantitation of peaks **8** and **11--13** ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). Mutation of this residue to Phe or Asn resulted in a reduced yield for **8** and **13**, while the yields of **11** and **12** both increased. The most remarkable changes were observed for mutants Ly487Ser and Lys487Gly, showing a significant increase in **12**, even up to 9.7 ± 1.1 g/100 g of lactose.

Discussion {#sec4}
==========

Prebiotic GOS produced from lactose by β-galactosidase enzymes are drawing a great deal of attention; they have been added to infant formula because their molecular size is similar to that of human milk oligosaccharides and because of their beneficial functions and positive effects on intestinal health.^[@ref25]−[@ref28]^ The beneficial functions of GOS were further shown by studies regarding calcium absorption, metabolic activities, and protection against colorectal cancer.^[@ref29]−[@ref32]^ To understand how different β-galactosidases synthesize such a range of GOS structures, and how they may be tailored to produce more specific GOS mixtures, it is essential to obtain detailed (three-dimensional) structural information about both the enzymes and their GOS products. Although several crystal structures of β-galactosidase enzymes have been determined and served to improve our understanding of the enzyme reaction mechanism,^[@ref33]−[@ref36]^ their detailed structure--function relationships are still largely unexplored, especially regarding their GOS product linkage specificity.

In this study, we have characterized the functional roles of eight amino acid residues in the active site of BgaD-D from *B. circulans* ATCC 31382, close to the substrate binding site, constituting four groups.

Arg185 and Glu601 Are Essential for Activity and Substrate Binding {#sec4.1}
------------------------------------------------------------------

Arg185 and Glu601 are located near the nonreducing end hydroxyl groups of the lactosyl moiety of LacNAc in subsite −1 ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). All six mutants of Arg185, and all 11 mutants of Glu601, had lost detectable enzyme activity. As shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A, Arg185 and Glu601 in 4YPJ correspond to Arg288 and Glu716 in *S. pneumoniae* BgaA, respectively; they are located at the −1 subsite of BgaA and are hydrogen-bonded to the 4-OH group of the galactosyl unit of LacNAc ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). Given the conservation of these residues, it is likely that Arg185 and Glu601 in BgaD-D have a similar essential function, namely assisting in the binding and positioning of the substrate.

![Superposition of the *B. circulans* ATCC 31382 BgaD-D residues (PDB code 4YPJ) subjected to mutagenesis \[(A) Arg185, Glu601, and Tyr511, (B) Trp570, Trp593, and Phe616, and (C) Asp481 and Lys487\] with the nucleophile mutant (E645Q) of BgaA of *S. pneumoniae* in complex with LacNAc (PDB code 4CUC). The color coding and labeling are the same as in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.](bi-2017-00207h_0004){#fig4}

Tyr511 Is Essential for Activity {#sec4.2}
--------------------------------

Residue Tyr511 is conserved among the GH2 family β-galactosidase enzymes ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}); both in BgaA and in BgaD, its OH group makes a hydrogen bond interaction (2.6 Å) to the nucleophilic Glu residue. The nearby nucleophilic residue Glu532 attacks the substrate while it is productively bound; a previous study proposed that Tyr511 assists in the catalytic mechanism by donating its proton to Glu532, before it attacks the substrate to form the covalent galactosyl--enzyme intermediate.^[@ref24]^ None of the mutants obtained were active. Our experimental results confirm that the hydroxyl group of Tyr511 is essential for enzymatic activity.

Residues Trp570, Trp593, and Phe616 Form an Aromatic Pocket Shaping the Substrate Binding Site {#sec4.3}
----------------------------------------------------------------------------------------------

Trp570 is located near the +1 subsite, while Trp593 and Phe616 are located near the −1 subsite ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B). From the 10 mutants of Trp570, Trp570Tyr retained 37.4 ± 0.4% of the WT activity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The *k*~cat~ of Trp570Tyr decreased 7.3-fold compared to that of the wild-type enzyme, while the *K*~m~ decreased 1.5-fold ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Trp570Phe retained 16.1 ± 1.0% of the WT activity; for the other substitutions, the activity was lower ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The *k*~cat~ of Trp570Phe decreased 4.5-fold, while the *K*~m~ increased 2.2-fold ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The kinetic parameters of Trp570Tyr and Trp570Phe show that the mutations at this site have a stronger influence on the turnover rate (*k*~cat~) than on *K*~m~ and may affect acceptor binding. The GOS yields of the Trp570Tyr and Trp570Phe mutants were comparable with that of the WT enzyme (63.5 ± 0.8 g of GOS from 100 g of initial lactose), while Trp570Leu can produce only 43.8 ± 0.7 g of GOS from 100 g of initial lactose ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). Mutants Trp570Tyr and Trp570Phe produced more of structure **8** and less of structures **11** and **17**, showing their preference for (β1→2) and (β1→3) over (β1→4) linkages. In contrast, Trp570Leu produced only 21.8 ± 0.5% of structure **8** compared to the wild type (100%), and the yield of structures further elongated from this (structure **13**) was too low to be quantified. The Trp570Leu yield of structure **11** was comparable to that of the wild-type enzyme. These results show the strong preference of this mutant to synthesize GOS with (β1→4) linkages. Notably, these three mutants also have a higher hydrolytic activity, as evidenced by a much higher yield of galactose (structure **1**) compared to that of the wild-type enzyme ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), i.e., 3.0, 5.9, and 10.1 times that of the wild type for Trp570Tyr, Trp570Phe, and Trp570Leu, respectively. Among the mutants of Trp593, activity was observed for only Trp593Tyr and Trp593Phe (3.3 ± 0.2 and 70.7 ± 0.7%, respectively) ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Both the *K*~m~ and the *k*~cat~ of Trp593Phe decreased ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}), resulting in a relatively low activity (70.7 ± 0.7%) compared to that of the wild-type enzyme ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). As shown in panels B and F of [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, the GOS yields of mutants Trp593Tyr and Trp593Phe were comparable to that of the wild-type enzyme. These two mutants synthesized more of structures **8** and **13** and less of structures **11** and **17**, showing their preference for (β1→2) and (β1→3) over (β1→4) linkages.

In the case of Phe616, the Phe616Tyr mutant had the highest activity, with 73.2 ± 0.6% of WT activity remaining, followed by Phe616Trp, which has 37.2 ± 1.5% of the WT activity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The kinetic parameters (*K*~m~ and *k*~cat~) of Phe616Tyr changed slightly compared to those of the wild-type enzyme ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). For Phe616Trp, the *K*~m~ increased while the *k*~cat~ decreased ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}), resulting in a much lower activity. Phe616Trp produced more of structures **11** and **17** and less of structures **8** and **13** ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}), showing its preference for synthesizing (β1→4) linkages. In contrast, Phe616Leu has a preference for synthesizing (β1→2) and (β1→3) linkages ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C and [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}).

The aromatic pocket formed by residues Trp570, Trp593, and Phe616 in BgaD shapes its active site. We found that mutations at these positions negatively affected enzyme activity, especially when the mutations were non-aromatic. Moreover, they changed the linkage preference and size of the products. For example, Trp570Leu produced only 21.8 ± 0.5% of structure **8** compared to the wild-type enzyme, and its elongation product, structure **13**, was not detectable. Apparently, the mutation enhanced the percentage of small oligosaccharides produced, achieving similar results as reported in a previous study.^[@ref37]^ Our results also show that Trp570 is essential for the transgalactosylation and hydrolysis activities, suggesting that it is involved in selection of the acceptor substrate, either water or carbohydrates. Together, the observed effects of mutations of residues in the aromatic pocket suggest that the geometry of this pocket is important to recognize and orient donor and acceptor substrates.

Asp481 and Lys487 Are Involved in Determining Linkage Specificity {#sec4.4}
-----------------------------------------------------------------

Asp481, Arg484, and Lys487 are located near subsite +1 ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). Mutations of the first residue (Asp481) dramatically reduced the enzyme activity. Among all mutants, only five (Glu, His, Ser, Asn, and Gln) retained some activity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Because Asp481 is relatively close to the acid/base catalyst Glu447 (3.9 Å), mutations at this position may affect the orientation and/or acidity of Glu447 and thus influence catalysis. Mutation Asp481Gln increased the substrate binding affinity (*K*~m~ decreased 2-fold) but decreased the turnover rate (*k*~cat~ decreased 16-fold) ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The GOS profiles of the Asp481 mutants changed strongly compared to that of the wild-type enzyme ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D). The amounts of all major GOS structures produced by the wild-type enzyme (structures **8**, **11**, and **13**) decreased, while that of structure **12** increased significantly ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}), similar to results found previously for mutations of Arg484.^[@ref11]^ It is also notable that with mutant Asp481Asn, the yield of allolactose (structure **4**) increased 2.3-fold compared to that of the wild-type enzyme ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D). The results show that the mutations at this site favor synthesis of GOS with (β1→3) and (β1→6) linkages. In BgaA of *S. pneumoniae*, the corresponding Asp599 (Asp481 in BgaD) forms a hydrogen bond with the 6-OH group of the GlcNAc moiety at the +1 subsite ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C); thus, considering its position and interaction, Asp481 may play a role in acceptor substrate binding.

The third residue in this group, Lys487, is relatively far from the +1 subsite ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). The activity of its mutants is relatively high compared to those of the other mutant enzymes except for Lys487Cys, retaining only 3.5 ± 0.4% of WT activity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Compared to those of the wild-type enzyme, the *K*~m~ and *k*~cat~ values of Lys487Ser showed only minor changes. In comparison, the *K*~m~ value of Lys487Gly increased by 57% and resulted in a lower catalytic efficiency (*k*~cat~/*K*~m~ = 1010). Compared with those of the wild-type enzyme, the GOS profiles and the relative amounts of the major structures did not change significantly for Lys487Met, Lys487Leu, or Lys487Gln. Mutants Lys487Phe, Lys487Ser, Lys487Gly, and Lys487Asn all have increased yields of structure **12** ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}E and [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). Especially for Lys487Gly, the yield of structure **12** is comparable to that of Arg484Ser and Arg484His.^[@ref11]^ The latter mutations thus favor the synthesis of GOS with (β1→3) linkages. Considering the slightly larger distance from the +1 site, mutations of Lys487 may change the microenvironment of the +1 subsite, therefore affecting the linkage specificity indirectly.

Conclusions {#sec5}
===========

In conclusion, we pinpointed several residues in the active site of BgaD that are important for the β-galactosidase reaction activity and specificity, by affecting substrate binding or transglycosylation specificity. Residues Arg185 and Glu601 at subsite −1 are essential for the β-galactosidase reaction because they affect substrate binding. A tyrosine residue near the catalytic residues (Tyr511) is also essential for the enzyme activity. An aromatic triplet (Trp570, Trp593, and Phe616) shaping the active site is important for correct substrate binding and determining the linkage distribution. Residues in or near subsite +1 (Asp481, Asp484, and Lys487) may affect the acceptor substrate orientation. Mutants derived produced large amounts of the trisaccharide β-[d]{.smallcaps}-Gal*p*-(1→3)-β-[d]{.smallcaps}-Gal*p*-(1→4)-[d]{.smallcaps}-Glc*p* (structure **12**) in the product mixture, thus leading to more diverse GOS mixtures with potential industrial applications. Our study thus provides important insights into the understanding of the structure--function relationships of β-galactosidase enzymes, especially regarding their GOS product linkage specificity, and provides guidance for rational protein engineering of these enzymes with the aim of producing tailor-made prebiotic GOS mixtures.
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